These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
647 related articles for article (PubMed ID: 2823092)
21. Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds. Balzarini J; Bernaerts R; Verbruggen A; De Clercq E Mol Pharmacol; 1990 Mar; 37(3):402-7. PubMed ID: 2156154 [TBL] [Abstract][Full Text] [Related]
22. Mechanism of cytostatic action of novel 5-(thien-2-yl)- and 5-(furan-2-yl)-substituted pyrimidine nucleoside analogues against tumor cells transfected by the thymidine kinase gene of herpes simplex virus. Bohman C; Balzarini J; Wigerinck P; Van Aerschot A; Herdewijn P; De Clercq E J Biol Chem; 1994 Mar; 269(11):8036-43. PubMed ID: 8132526 [TBL] [Abstract][Full Text] [Related]
23. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons. Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636 [TBL] [Abstract][Full Text] [Related]
24. Differential metabolism of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by equine herpesvirus type 1- and herpes simplex virus-infected cells. Kit S; Ichimura H; De Clercq E Antiviral Res; 1987 Aug; 8(1):41-51. PubMed ID: 2825591 [TBL] [Abstract][Full Text] [Related]
25. Establishment of mutant murine mammary carcinoma FM3A cell strains transformed with the herpes simplex virus type 2 thymidine kinase gene. Shimizu K; Ren L; Ayusawa D; Seno T; Balzarini J; De Clercq E Cell Struct Funct; 1986 Sep; 11(3):295-301. PubMed ID: 3021345 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and cellular uptake of 2'-substituted analogues of (E)-5-(2-[125I]iodovinyl)-2'-deoxyuridine in tumor cells transduced with the herpes simplex type-1 thymidine kinase gene. Evaluation as probes for monitoring gene therapy. Morin KW; Atrazheva ED; Knaus EE; Wiebe LI J Med Chem; 1997 Jul; 40(14):2184-90. PubMed ID: 9216837 [TBL] [Abstract][Full Text] [Related]
27. Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase. Degrève B; Esnouf R; De Clercq E; Balzarini J Mol Pharmacol; 2001 Feb; 59(2):285-93. PubMed ID: 11160865 [TBL] [Abstract][Full Text] [Related]
28. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU). De Clercq E Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733 [TBL] [Abstract][Full Text] [Related]
29. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine. Wilber BA; Docherty JJ J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603 [TBL] [Abstract][Full Text] [Related]
30. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line. Balzarini J; De Clercq E; Ayusawa D; Seno T Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443 [TBL] [Abstract][Full Text] [Related]
31. 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells. Cristofoli WA; Wiebe LI; De Clercq E; Andrei G; Snoeck R; Balzarini J; Knaus EE J Med Chem; 2007 Jun; 50(12):2851-7. PubMed ID: 17518459 [TBL] [Abstract][Full Text] [Related]
32. The cytostatic activity of 5-(1-azidovinyl)-2'-deoxyuridine (AzVDU) against herpes simplex virus thymidine kinase gene-transfected FM3A cells is due to inhibition of thymidylate synthase and enhanced by UV light (lambda = 254 nm) exposure. Balzarini J; Andrei G; Kumar R; Knaus EE; Wiebe LI; De Clercq E FEBS Lett; 1995 Oct; 373(1):41-4. PubMed ID: 7589430 [TBL] [Abstract][Full Text] [Related]
33. Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cells. Bubley G; Crumpacker C; De Clercq E; Schnipper L Virology; 1983 Sep; 129(2):490-2. PubMed ID: 6312685 [TBL] [Abstract][Full Text] [Related]
34. Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer. Wildner O; Blaese RM; Candotti F Cancer Res; 1999 Oct; 59(20):5233-8. PubMed ID: 10537302 [TBL] [Abstract][Full Text] [Related]
35. Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA. Balzarini J; De Clercq E; Ayusawa D; Seno T Biochem J; 1984 Jan; 217(1):245-52. PubMed ID: 6696722 [TBL] [Abstract][Full Text] [Related]
36. Substrate specificity of feline and canine herpesvirus thymidine kinase. Solaroli N; Johansson M; Persoons L; Balzarini J; Karlsson A Antiviral Res; 2008 Aug; 79(2):128-32. PubMed ID: 18455811 [TBL] [Abstract][Full Text] [Related]
37. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs. Wildner O; Hoffmann D; Jogler C; Uberla K Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232 [TBL] [Abstract][Full Text] [Related]
38. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine. Docherty JJ; Dobson AT; Trimble JJ; Jennings BA Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822 [TBL] [Abstract][Full Text] [Related]
39. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells. Chou TC; Lopez C; Colacino JM; Feinberg A; Watanabe KA; Fox JJ; Philips FS Mol Pharmacol; 1984 Nov; 26(3):587-93. PubMed ID: 6092904 [TBL] [Abstract][Full Text] [Related]
40. Apoptosis induced by (E)-5-(2-bromovinyl)-2'-deoxyuridine in varicella zoster virus thymidine kinase-expressing cells is driven by activation of c-Jun/activator protein-1 and Fas ligand/caspase-8. Tomicic MT; Friedrichs C; Christmann M; Wutzler P; Thust R; Kaina B Mol Pharmacol; 2003 Feb; 63(2):439-49. PubMed ID: 12527816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]